Bumrungrad leads fragmented medical tourism market

By AI, Created 10:06 AM UTC, May 20, 2026, /AGP/ – The medical tourism market remains highly fragmented, with Bumrungrad International Hospital holding the largest reported share in 2024 at 0.4%. A new Business Research Company report says competition is being shaped by personalized care tools, international accreditations, and partnerships that help providers attract cross-border patients.

Why it matters: - The medical tourism market is still split across many providers, so small share gains can materially change competitive positioning. - Patients are choosing providers based on price, quality, waiting times, and international standards, which puts pressure on hospitals to differentiate beyond basic medical services. - Request a free sample of the report for additional market detail.

What happened: - The Business Research Company said Bumrungrad International Hospital led global medical tourism sales in 2024 with a 0.4% market share. - The report said the top 10 players accounted for 1.8% of total market revenue in 2024. - The report identified the market as dominated by international hospital groups, specialized healthcare providers, and accredited clinics. - The report said major companies include Apollo Hospitals Enterprise Ltd, Fortis Healthcare, Bangkok Dusit Medical Services PCL, KPJ Healthcare Berhad, Saudi German Hospitals Group, Gleneagles Hospital, Samitivej Hospitals, NTT Medical Center Tokyo, and Hospital de Clínicas Caracas.

The details: - Bumrungrad International Hospital’s international patient services division offers cardiology, oncology, orthopedics, cosmetic surgery, and preventive health check-ups. - The division is built around advanced medical technology, personalized patient care, and end-to-end services for international patients. - Other leading players listed with market shares include Apollo Hospitals Enterprise Ltd at 0.2%, Fortis Healthcare at 0.2%, Bangkok Dusit Medical Services PCL at 0.1%, KPJ Healthcare Berhad at 0.1%, Saudi German Hospitals Group at 0.1%, Gleneagles Hospital at 0.1%, Samitivej Hospitals at 0.1%, NTT Medical Center Tokyo at 0.05%, and Hospital de Clínicas Caracas at 0.05%. - Major raw material suppliers listed in the market include GE HealthCare, Siemens Healthineers, Philips Healthcare, Medtronic Plc, Stryker Corporation, B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Cardinal Health Inc., Zimmer Biomet Holdings Inc., Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Nipro Corporation, and Smith & Nephew Plc. - Major wholesalers or distributors listed include McKesson Corporation, Cencora, Owens & Minor Inc., Henry Schein Inc., Medline Industries LP, Zuellig Pharma Holdings Ltd., DKSH Holding Ltd., Sinopharm Group Co. Ltd., PHOENIX Pharma SE, Alliance Healthcare, EBOS Group Limited, Celesio AG, IMRES BV, and Transmedic Pte Ltd. - Major end users listed include Acibadem Healthcare Group, Narayana Health, Wockhardt Hospitals, Max Healthcare Institute Ltd, Raffles Medical Group, and Mediclinic International. - The report said the competitive field also includes clinics and medical tourism providers such as Asian Heart Institute, Asklepios Kliniken Verwaltungsgesellschaft mbH, Seoul National University Hospital, Medicana Haznedar Hospital Istanbul, Carlsbad Clinic, CHRISTUS MUGUERZA, Clifford Hospital, University Medical Center, Emsey Hospital, German International Clinic, Medipol Mega University Hospital, Beijing Saint Lucia Consulting Ltd, Estetik International Istanbul, CubaHeal Medical Tourism Inc, International Diagnostic Center Frankfurt, Hisar Hospital Intercontinental, North American Specialty Hospital, Travcure Medical Tourism Consultants, Kolan International Hospital, Elite Skin Rejuvenation, Clinica Sao Vicente, Specijalna bolnica Sv. Katarina, Hospital Do Coração, Al Shifa Al Khaleeji Medical Centre, Intermed Consult, and Anadolu Medical Center Kocaeli.

Between the lines: - The report frames medical tourism as a scale game with modest concentration and high operational complexity. - Accreditation, skilled staff, cross-border patient management, and advanced infrastructure act as barriers, but not enough to produce a tightly consolidated market. - Personalized health assessment tools are emerging as a differentiator because they can improve engagement and support preventive care across the patient journey. - In December 2025, Bumrungrad Hospital Public Company Limited launched smart personalized healthmatch and biological age testing, using AI to analyze age, lifestyle, and medical history. - The report grouped market strategies around recognition-driven awards, integrated healthcare and travel services, integrative wellness, and luxury surgical retreats.

What’s next: - The report expects competition to intensify as demand rises for cost-effective treatment, lower wait times, and specialized procedures. - Providers that expand international patient services, add digital health tools, and form stronger partnerships with travel facilitators are likely to strengthen their market position. - The full report is available here.